Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -432.41% | -68.40% | 185.39% | 120.61% | -0.43% |
| Total Depreciation and Amortization | 4.28% | 0.00% | -16.24% | 5.57% | 35.65% |
| Total Amortization of Deferred Charges | -4.55% | 15.79% | -24.00% | -- | -- |
| Total Other Non-Cash Items | 20,558.33% | -90.77% | -88.00% | -52.27% | 80.94% |
| Change in Net Operating Assets | 78.09% | -239.32% | 221.88% | -300.60% | -72.20% |
| Cash from Operations | 2,079.01% | -97.31% | 65.22% | 32.49% | 36.78% |
| Capital Expenditure | -112.93% | 59.15% | 77.50% | -26.71% | -42.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.06% | -14.29% | 56.92% | -12,900.00% | 95.45% |
| Cash from Investing | -69.26% | 52.56% | 76.48% | -33.05% | -40.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 5,150.00% | -93.59% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,400.00% | 106.54% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 892.79% | -109.12% | 374.82% | -34.30% | -105.32% |